Skip to main content

Roche's Dx Sales Increase 3 Percent in Q1

NEW YORK (GenomeWeb News) – Roche reported today that first-quarter revenues for its diagnostics division, which includes its molecular diagnostics and applied science businesses, rose 3 percent to CHF2.36 billion ($2.06 billion) year over year.

The Swiss drugs and diagnostics giant said that its molecular diagnostics business brought in revenues of CHF294 million for the quarter with growth driven by automated real-time PCR platforms and blood-screening products.

Its applied science business generated revenues of CHF196 million for the quarter led by the sale of DNA sequencing products and microarrays, which both posted high double-digit growth, said Roche. The firm's tissue diagnostics business had Q1 sales of CHF106 million, driven by last year's $3.4 billion acquisition of Ventana Medical Systems.

Overall, the Roche Group had first-quarter revenues of CHF11.58 billion, up 7 percent year over year. That growth was driven largely by its pharmaceutical division, which posted 8 percent growth to CHF9.21 billion.

"Sales in both divisions continued to grow significantly faster than their respective markets," Roche CEO Severin Schwan said in a statement. "We are therefore confident that we can achieve our full-year targets."

Roche said that it will update its full-year outlook when it releases its half-year results. Earlier this year, the firm said that it expects mid-single digit sales growth for 2009, but that was before it inked the definitive agreement to acquire the remaining interest in Genentech.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.